Martine A Rothblatt Insider Trading Activity
Every SEC Form 4 transaction reported by Martine A Rothblatt, sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Is Martine A Rothblatt buying or selling?
Martine A Rothblatt reported 0 open-market buys ($0) and 301 sells ($1.1B) across 301 Form 4 filings at 1 company — a net selling position of $1.1B.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 20, 2026)
Insider sentiment
Net sellingNet insider flow of $1.1B in net selling, filed between Jan 7, 2019 – Jul 20, 2026.
Companies Martine A Rothblatt files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | UTHRUNITED THERAPEUTICS Corp | 301 |
Recent Martine A Rothblatt transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 20, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jul 17, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.0M |
| Jul 16, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.0M |
| Jul 14, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jul 13, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jul 10, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jul 9, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.3M |
| Jul 8, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.3M |
| Jul 7, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jul 2, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.3M |
| Jul 2, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jul 1, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jun 30, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 29, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 26, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 25, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 24, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 24, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jun 22, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jun 18, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 17, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 16, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 15, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.1M |
| Jun 12, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
| Jun 11, 2026 | UTHR | Chairperson & CEO | Sale | 9.5K | $5.2M |
Showing the 25 most recent filings of 301. Screen every filing.
Martine A Rothblatt insider trading FAQ
Is Martine A Rothblatt buying or selling?
Across 301 SEC Form 4 filings, Martine A Rothblatt reported 0 open-market purchases totaling $0 and 301 sales totaling $1.1B — a net selling position of $1.1B.
Which companies does Martine A Rothblatt file Form 4s for?
Martine A Rothblatt has reported insider transactions at 1 company, most often UNITED THERAPEUTICS Corp (UTHR).
How far back does Martine A Rothblatt's filing history go?
Trabud holds Martine A Rothblatt's SEC Form 4 filings from Jan 7, 2019 – Jul 20, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Martine A Rothblatt's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Martine A Rothblatt and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener